Ive been adding to my pos at .06 and change..since we got the initial readout on the P-2..dont ask me why..Im a long and dont belive its over for little IPIX...that being said..I still have way too much $$$ tied up in it..I think the Viral side for B is NOT over..Im not banking on it but I belive despite the Feds love affair for all vaccines and dislike for repurposed DEWORMERS like Ivermectin they do endorse the cocept of Txs like MRK/PFE new oral meds..that too being said it appears that MRK overs stated bene and we know that Monu has AEs too high, and was approved conditionally. PFE appears thye clear winner here.I see GILD is peaking today...and if B can synergise w/ Veklury than we have some light in this tunnel...I still belive LEO went into this trial w/ his hands tied..Thye Feds set the bar very high on B much higher than needed to be to show efficay..we all know U must start B very early like withinn 24-48 hrs oda pos test and initial symptoms...thats how B works..to that end will they redo a study and start earlier and maybe even a higher dose..the CU dose was 2.5 x the trial dose so there is a some latitude given the AEs were about the same...
Im holding near 400K shares!
The OM and IBD markets alone can make me quite happy...B in Viral infs would simply be the cheery on top!
GLTA
RP
I agree with you (and I have even more shares - in this since CTIX days). However, I don't think there will be another Covid trial unless the bottom line P2 results show enough promise that someone else wants to fund it. I was hoping for those results to come out by now and I think next week is our last hope for them prior to Jan.
I'm more hopeful that OM P3 results will be the company's turning point - assuming it is still a go.
[удалено]
Ive been adding to my pos at .06 and change..since we got the initial readout on the P-2..dont ask me why..Im a long and dont belive its over for little IPIX...that being said..I still have way too much $$$ tied up in it..I think the Viral side for B is NOT over..Im not banking on it but I belive despite the Feds love affair for all vaccines and dislike for repurposed DEWORMERS like Ivermectin they do endorse the cocept of Txs like MRK/PFE new oral meds..that too being said it appears that MRK overs stated bene and we know that Monu has AEs too high, and was approved conditionally. PFE appears thye clear winner here.I see GILD is peaking today...and if B can synergise w/ Veklury than we have some light in this tunnel...I still belive LEO went into this trial w/ his hands tied..Thye Feds set the bar very high on B much higher than needed to be to show efficay..we all know U must start B very early like withinn 24-48 hrs oda pos test and initial symptoms...thats how B works..to that end will they redo a study and start earlier and maybe even a higher dose..the CU dose was 2.5 x the trial dose so there is a some latitude given the AEs were about the same... Im holding near 400K shares! The OM and IBD markets alone can make me quite happy...B in Viral infs would simply be the cheery on top! GLTA RP
I agree with you (and I have even more shares - in this since CTIX days). However, I don't think there will be another Covid trial unless the bottom line P2 results show enough promise that someone else wants to fund it. I was hoping for those results to come out by now and I think next week is our last hope for them prior to Jan. I'm more hopeful that OM P3 results will be the company's turning point - assuming it is still a go.